Medicamen Biotech Ltd-$ - 531146 - Intimation Of Book Clsoure And Record Date In Accordance With Regulation 42 Of The SEBI (Listing Obligationa And Disclosure Requirements) Regulation 2015BSE filing · raw filing ↗
17 Aug 2026
⚑ Filing
Copy of Newspaper PublicationNSE filing · raw filing ↗
17 Aug 2026
⚑ Filing
Medicamen Biotech Ltd-$ - 531146 - Corpoarte Action - Fixes Record Date As September 19, 2026 For The Purpose Of Declaration Of Final Dividend For The FY 2025-26.BSE filing · raw filing ↗
17 Aug 2026
⚑ Filing
Medicamen Biotech Ltd-$ - 531146 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
Disclosure under SEBI Takeover RegulationsNSE filing · raw filing ↗
28 May 2026
⚑ Filing
Statement of deviation(s) or variation(s) under Reg. 32NSE filing · raw filing ↗
28 May 2026
⚑ Filing
Copy of Newspaper PublicationNSE filing · raw filing ↗
27 May 2026
⚑ Filing
Q4 FY26 results filed — revenue ₹61 Cr (+104.8% YoY), PAT ₹4 Cr (+138.6% YoY)NSE filing · raw filing ↗
Ex-date 19 Sep 2025
⚑ Corp action
Dividend — ₹1.00 per shareNSE filing · record 19 Sep 2025
Ex-date 19 Sep 2024
⚑ Corp action
Dividend — ₹1.00 per shareNSE filing
Ex-date 20 Sep 2023
⚑ Corp action
Dividend — ₹1.00 per shareNSE filing
Ex-date 19 Sep 2022
⚑ Corp action
Dividend — ₹1.00 per shareNSE filing
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
